BRIEF published on 10/27/2025 at 15:30, 1 year ago Chromatin Bioscience Collaborates with Purespring Therapeutics Gene Therapy Kidney Health Chromatin Bioscience Purespring Therapeutics Synthetic Promoters
PRESS RELEASE published on 10/27/2025 at 15:25, 1 year ago Chromatin Bioscience Announces Collaboration with Purespring Therapeutics Chromatin Bioscience partners with Purespring Therapeutics for gene therapy collaboration, leveraging chromatinLENS platform to enhance targeted genetic therapies Collaboration Gene Therapy Chromatin Bioscience Purespring Therapeutics ChromatinLENS
Published on 11/13/2026 at 18:30, 32 minutes ago Sparta Capital Ltd. Announces Application to the Ontario Securities Commission to Become a Reporting Issuer in Ontario
Published on 11/13/2026 at 18:05, 57 minutes ago Integrated BioPharma Reports Results for its Quarter Ended September 30, 2026
Published on 11/13/2026 at 17:25, 1 hour 37 minutes ago Sekur Private Data Raises SekurOne Price 25% to US$3,750 Per Year
Published on 11/13/2026 at 15:40, 3 hours 22 minutes ago Vulcan Minerals Inc. - Review and Update on Affiliated Company Atlas Salt Inc.
Published on 11/13/2026 at 15:30, 3 hours 32 minutes ago Road Access Completed Drill Program to Begin
Published on 11/13/2026 at 18:04, 58 minutes ago EQS-Adhoc: CHAPTERS Group AG: Capital Increase from Authorized Capital Resolved
Published on 11/13/2026 at 11:35, 7 hours 27 minutes ago ENGIE and Google to partner on energy solutions for a potential data center project near Châteauroux, France
Published on 11/12/2026 at 23:12, 19 hours 49 minutes ago Belgrano continues the implementation of its public share buyback offer (OPRA)
Published on 11/12/2026 at 18:36, 1 day ago AXA: Information relating to the number of voting rights and shares making up the share capital on 31/10/2026
Published on 11/12/2026 at 18:00, 1 day 1 hour ago Information concerning the total number of voting rights and shares in the share capital as of November 12, 2026
Published on 11/12/2026 at 17:40, 1 day 1 hour ago Financial information for the period ended 30 September 2026
